HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H M Kvasnicka Selected Research

Reticulin (Reticular Fiber)

12/2006Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.
4/2006Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
3/2006Morphology of the bone marrow after stem cell transplantation.
1/2004Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
11/2003Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
3/2003Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
2/2001Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
1/2001Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.
8/2000Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation.
8/2000Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H M Kvasnicka Research Topics

Disease

21Primary Myelofibrosis (Myelosclerosis)
01/2007 - 01/2000
15BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2004 - 01/2000
12Fibrosis (Cirrhosis)
12/2006 - 01/2000
6Splenomegaly
04/2006 - 01/2001
4Neoplasms (Cancer)
01/2018 - 02/2000
4Philadelphia Chromosome
11/2004 - 07/2000
4Myeloproliferative Disorders (Myeloproliferative Disorder)
01/2004 - 01/2000
3Essential Thrombocythemia
10/2014 - 10/2004
3Anemia
04/2006 - 01/2001
2Polycythemia Vera
12/2006 - 10/2004
2Thrombocytosis (Thrombocythemia)
10/2005 - 11/2002
2Polycythemia (Erythrocytosis)
01/2005 - 04/2001
2Leukocytosis (Pleocytosis)
05/2002 - 03/2001
2Carcinoma (Carcinomatosis)
06/2000 - 02/2000
1Melanoma (Melanoma, Malignant)
01/2018
1Prodromal Symptoms
12/2006
1Pancytopenia
03/2006
1Blast Crisis (Blast Phase)
01/2006
1Scleredema Adultorum
01/2004
1Edema (Dropsy)
01/2004
1Residual Neoplasm
01/2003
1Spinal Cord Diseases
11/2002
1Granuloma
11/2002
1Lyme Disease (Disease, Lyme)
11/2002
1Niemann-Pick Diseases (Niemann Pick Disease)
11/2002
1Lymphoma (Lymphomas)
11/2002
1Polyploidy
11/2002
1Q Fever (Fever, Q)
11/2002
1Type B Niemann-Pick Disease
11/2002
1Hemorrhage
05/2002
1Thrombosis (Thrombus)
05/2002
1Refractory Anemia
03/2001
1Chronic Bronchitis
01/2000
1Bronchopneumonia
01/2000

Drug/Important Bio-Agent (IBA)

13Reticulin (Reticular Fiber)IBA
12/2006 - 01/2000
7InterferonsIBA
03/2004 - 01/2000
6Hydroxyurea (Hydrea)FDA LinkGeneric
10/2005 - 01/2000
5CollagenIBA
12/2006 - 01/2000
3Hemoglobins (Hemoglobin)IBA
10/2014 - 01/2001
3Imatinib Mesylate (Gleevec)FDA Link
11/2004 - 03/2004
3Biological ProductsIBA
01/2003 - 01/2000
2anagrelide (Agrylin)FDA LinkGeneric
10/2005 - 11/2002
2IronIBA
01/2005 - 01/2000
2Tyrosine Kinase InhibitorsIBA
10/2004 - 03/2004
2Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2000 - 02/2000
1Small Interfering RNA (siRNA)IBA
01/2018
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2018
1CytokinesIBA
10/2004
1Phenobarbital (Luminal)FDA Link
10/2004
1Inosine Monophosphate (IMP)IBA
06/2003
1SphingolipidsIBA
11/2002
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
11/2002
1SphingomyelinsIBA
11/2002
1EnzymesIBA
11/2002
1Pharmaceutical PreparationsIBA
11/2002
1Muramidase (Lysozyme)IBA
11/2002
1Peroxidase (Myeloperoxidase)IBA
11/2002
1FibrinIBA
11/2002
1AntibodiesIBA
11/2002
1AcidsIBA
11/2002
1chloroacetate esteraseIBA
11/2002
1Alkaline PhosphataseIBA
05/2002
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2002
1monoethylglycinexylidide (L 86)IBA
05/2002
1ErythropoietinFDA Link
04/2001
1Busulfan (Busulfex)FDA Link
07/2000
1Interferon-alpha (Interferon Alfa)IBA
07/2000
1Lewis X AntigenIBA
06/2000

Therapy/Procedure

16Therapeutics
01/2006 - 02/2000
5Drug Therapy (Chemotherapy)
02/2006 - 01/2000
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2002 - 08/2000
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2007 - 01/2005
2Stem Cell Transplantation
01/2007 - 01/2005
2Transplantation
03/2006 - 03/2004
1Radiotherapy
02/2006
1Homologous Transplantation
08/2000
1Laser Therapy (Surgery, Laser)
06/2000